KOD

KODIAK SCIENCES INC

KOD·50015M109·US·Common Stock·Healthcare - Biotechnology-Activist

KOD (KODIAK SCIENCES INC) is held by 109 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($776.1M), BlackRock, Inc. ($161.1M), PRICE T ROWE ASSOCIATES INC /MD/ ($126.6M). Net institutional sentiment: Mixed.

109
Holders
(7 Elite)
$1.9B
Total Value
61% (115)
Consensus
70 buying - 45 selling
13F: Insider & Congress: Updated regularly
KOD

Smart Money Verdict

View all
Loading verdict
Held by 109 funds
7 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Sep 30, 2026 · Activists Sep 30, 2026 · Congress none

ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP35.0%Sep 30, 2026
InsiderBLBAKER BROS. ADVISORS LPBuy $102KSep 29, 2026
InsiderBLBAKER BROS. ADVISORS LPBuy $52KSep 29, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
19.9M$776.1M3.9%+144.18%
0
Increased
4.1M(+5.1%)$161.1M0.0%+416.79%
32
Increased
3.2M(+59.3%)$126.6M0.0%+146.48%
43
Increased
2.4M(+7.5%)$94.3M0.0%+130.70%
32
Increased
2.3M(+37.1%)$90.2M0.0%+168.20%
39
Increased
1.8M(+5.1%)$70.3M0.0%+112.50%
31
First report
1.5M$59.5M0.0%+108.14%
0
Unchanged
1.5M$58M0.5%+190.02%
0
Increased
1.1M(+6.3%)$41.4M0.0%+114.81%
31
Increased
968,037(+40.2%)$37.7M0.1%+160.61%
39
Increased
793,613(+81.9%)$30.9M0.0%+170.47%
44
Increased
532,819(+46.0%)$20.8M0.0%+111.26%
39
Decreased
500,000(-13.0%)$19.5M0.0%+1042.98%
0
Increased
473,001(+375.5%)$18.4M0.0%+126.06%
46
Decreased
435,029(-15.7%)$16.9M0.0%+554.28%
0
Increased
383,709(+27.8%)$14.9M0.0%+208.98%
35
Decreased
366,827(-6.3%)$14.3M0.0%+199.14%
0
Increased
358,056(+2.4%)$13.9M0.0%+101.06%
29
Decreased
312,595(-0.9%)$12.2M0.0%+499.74%
0
Increased
291,969(+13.1%)$11.4M0.0%+112.18%
31

Showing 1-20 of 120

1 / 6
KODKODKODIAK SCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used